Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126890074 | 12689007 | 4 | F | 20160502 | 20160921 | 20160826 | 20160927 | EXP | PHHY2016TW115034 | NOVARTIS | 50.20 | YR | F | Y | 67.00000 | KG | 20160927 | MD | TW | TW |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126890074 | 12689007 | 1 | PS | TASIGNA | NILOTINIB | 1 | Oral | 600 MG, UNK | 22068 | 600 | MG | CAPSULE | |||||||
126890074 | 12689007 | 2 | SS | TASIGNA | NILOTINIB | 1 | Oral | UNK | 22068 | CAPSULE |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
126890074 | 12689007 | 1 | Chronic myeloid leukaemia |
Outcome of event
Event ID | CASEID | OUTC COD |
---|---|---|
126890074 | 12689007 | OT |
126890074 | 12689007 | HO |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126890074 | 12689007 | Arrhythmia | |
126890074 | 12689007 | Back pain | |
126890074 | 12689007 | Cardiac valve disease | |
126890074 | 12689007 | Chest discomfort | |
126890074 | 12689007 | Coronary artery disease | |
126890074 | 12689007 | Palpitations |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
126890074 | 12689007 | 1 | 20150930 | 0 | ||
126890074 | 12689007 | 2 | 20160711 | 0 |